SubB2M results for Breast and Ovarian are both due in the next month.
The Exosomes scientific results presented a few weeks ago were excellent.
Some ppl here a dissing big time....but they obviously do not have the knowledge to understand what they're reading.
Likewise...the Sub results due will come, and don't point to any failure on the past of management if they are a few days late.
Meanwhile...Grail released results last week that they called "promising" but were very unimpressive. But I'm sure the IIQ critics know all about that...not.
Bottom line....if the Sub2 results are good it won't matter who is running the company. Big Pharma will come knocking.....and either licensing deals will be done, or there will be a takeover offer.
The current mkt cap is a steal for the potential this company offers.....and sometimes the market offers opportunities like that.
IIQ General Discussion, page-92
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.010(2.27%) |
Mkt cap ! $50.18M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 43.5¢ | $15.99K | 35.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 507 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 1925 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |